Stevanato Group (NYSE:STVN) Releases FY 2025 Earnings Guidance

Stevanato Group (NYSE:STVN) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided EPS guidance of 0.544-0.587 for the period, compared to the consensus EPS estimate of 0.570. The company issued revenue guidance of $1.2 billion-$1.3 billion, compared to the consensus revenue estimate of $1.2 billion.

Stevanato Group Trading Down 2.5 %

Shares of STVN opened at €18.84 ($20.26) on Thursday. The stock’s fifty day simple moving average is €21.40 and its 200-day simple moving average is €20.51. The firm has a market capitalization of $5.71 billion, a PE ratio of 40.09, a price-to-earnings-growth ratio of 7.18 and a beta of 0.56. Stevanato Group has a 12-month low of €16.56 ($17.81) and a 12-month high of €33.49 ($36.01). The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22.

Stevanato Group (NYSE:STVN) last released its earnings results on Thursday, March 6th. The company reported €0.20 ($0.22) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of €0.20 ($0.22). Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. As a group, research analysts predict that Stevanato Group will post 0.5 earnings per share for the current year.

Analyst Ratings Changes

STVN has been the subject of several recent research reports. Morgan Stanley reiterated an “equal weight” rating and set a $23.00 target price (down previously from $24.00) on shares of Stevanato Group in a research report on Tuesday, December 3rd. Bank of America lifted their price objective on Stevanato Group from $24.00 to $26.00 and gave the stock a “buy” rating in a research note on Friday, December 13th. Finally, Wolfe Research started coverage on Stevanato Group in a research note on Friday, December 13th. They issued an “outperform” rating and a $28.00 target price on the stock. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of €28.60 ($30.75).

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.